A sampling of recent reports shows just how much immuno-oncology continues to grow. Last month, GrandView Research projected a more than doubling of the global cancer immunotherapy market, from the $58.1 billion it tallied in 2018, to $126.9 billion by 2026. As GEN noted when it ranked the top immuno-oncology startups in February, market projections range from $124.88 billion (Transparency Market Research) to $173 billion (Market Research Engine) by 2024.
{iframe}https://www.genengnews.com/a-lists/top-10-immuno-oncology-collaborations-3/?utm_medium=newsletter&utm_source=GEN+Daily+News+Highlights&utm_content=01&utm_campaign=GEN+Daily+News+Highlights_20190325&ajs_uid=5901D8426578G1Y&oly_enc_id=5901D8426578G1Y&ajs_trait_oebid=9675B9130356B7S{/iframe}